CAPACITY DEVELOPMENT WORKSHOP ON HEALTH SYSTEM DVEVELOPMENT
100 likes | 290 Vues
CAPACITY DEVELOPMENT WORKSHOP ON HEALTH SYSTEM DVEVELOPMENT. MAY 24, 2007 Alexandria GROUP I Facilitator: Dr. Zafar Mirza. Participants. Dr. Werner Buehler Dr. Ehsanullah Tarin Dr. Ali Garraoui Dr. Nasreen Abdul Razzak Dr. Amal Bassili Dr. Joumana Hermez Dr. Nasr El Tantawy
CAPACITY DEVELOPMENT WORKSHOP ON HEALTH SYSTEM DVEVELOPMENT
E N D
Presentation Transcript
CAPACITY DEVELOPMENT WORKSHOP ON HEALTH SYSTEM DVEVELOPMENT MAY 24, 2007 Alexandria GROUP I Facilitator: Dr. Zafar Mirza
Participants • Dr. Werner Buehler • Dr. Ehsanullah Tarin • Dr. Ali Garraoui • Dr. Nasreen Abdul Razzak • Dr. Amal Bassili • Dr. Joumana Hermez • Dr. Nasr El Tantawy • Dr. Ali Khader • Dr. Ahmed Latif • Dr. Balgacem Sabri • Dr. Sanaa Nafa • Dr. Khushhal Khan Zaman
I. Review of the existing situation • Governance and Leadership role of the MoH • Lacks strategic vision / planning capacities • Decision making based on a single study – insufficient evidence • Dominant private sector • Equity and Ethical issues • Lack of transparency and Accountability • A National Medicine Policy and a National Essential drug list is available, however, minimal regulation of medicines, medical devices and health technologies
Review ……Cond 2. Financing • Low middle income country • No social Health Insurance System • 50 % population buys medicines out of pocket • Willingness to double the budget for buying medicines and medical devices
Review…..Continued 3. Organization and Management • A Pharmacy Directorate at the MoH - Registration department - Federal Inspectorate - Procurement department - Traditional Medicine • Two linked organizations: - National Quality Control Lab. - National Pharmacy Council • However, Irrational use of drugs does not feature as a responsibility of any of the existing authorities • Procurement and distribution of medicines/ medical devices is not needs based • Adhoc usages / non utilization
Review ……Cond 4. Information Systems • No reliable information on the extent of Irrational use of medicines / medical devices • No supervisory and / or Monitoring and Evaluation systems in Place
II. Recommendations • Establishing a Regulatory authority -Formation of a Multi stakeholder Regulatory body (MoH, Clinicians, Hospital management, Pharmaceutical companies, Medical Schools, NGOs etc) to regulate irrational drug use in the public and private sectors • Comprehensive Strategic Plan: including ethical standards, treatment / prescription guidelines, training Manuals, Procurement policies, M and E • Awareness / Education - Political Awareness / Advocacy - Consumers education- Public Health campaign - Education of doctors / prescribers on rational use of drugs - Changes in medical curricula
Recommendations • Managerial and Financial: Needs based procurement and distribution of medicines and medical equipment Transparency in the Purchase of medicines and medical devices Strengthening the evidence base – improving information systems ( preparation of a database) Establishing Monitoring and Evaluation mechanisms- monitoring Indicators
Recommendations • Enforcing essential drugs list through enhanced supervision • Preventing use of Over the Counter drugs limiting availability of drugs without prescriptions • Establishing a mechanism of Prescription audits • Applying Quality Assurance techniques • Promoting use of generic medicines